Aug 13, 2021 05:13 PM (GMT+8) · EqualOcean
Xinyitang announced that in order to meet the needs of the company's strategic development, the company plans to invest 100 million yuan to establish a wholly-owned subsidiary xinyitang Pharmaceutical (Shanxi) Co., Ltd. (the specific name shall be subject to the approval of the competent authority) to further expand the company's business and ensure the smooth implementation of the company's future industrial strategy.